Not applicableStudy completedNCT01505699What this trial is testingBiomarkers in Samples From Patients With B-Cell Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Eastern Cooperative Oncology Group 186
Very early researchNot Yet RecruitingNCT06559644What this trial is testingHema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute LeukemiaWho this might be right forLeukemia, Myeloid, AcuteB-cell Acute Lymphoblastic Leukemia The First Affiliated Hospital of Soochow University 20
Early research (Phase 1)UnknownNCT03962465What this trial is testingPhase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALLWho this might be right forB-cell Acute Lymphoblastic Leukemia University of Virginia 36
Testing effectiveness (Phase 2)Ended earlyNCT03860844What this trial is testingIsatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia Sanofi 67
Very early researchUnknownNCT04129099What this trial is testingGC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALLWho this might be right forB-cell Acute Lymphoblastic Leukemia Hebei Yanda Ludaopei Hospital 18
Testing effectiveness (Phase 2)Study completedNCT00134004What this trial is testingFludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 210
Large-scale testing (Phase 3)Study completedNCT00661999What this trial is testingDarbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With CancerWho this might be right forAnemiaLeukemiaLymphoma+4 more Mayo Clinic 502
Early research (Phase 1)Looking for participantsNCT05535855What this trial is testingUCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1Who this might be right forAcute Lymphoid LeukemiaAcute Lymphoblastic Leukemia University of Colorado, Denver 29
Not applicableEnded earlyNCT01408043What this trial is testingEtoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin LymphomaWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell Lymphoma+31 more Case Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT00005852What this trial is testingBone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow TransplantWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)WithdrawnNCT04029038What this trial is testingModified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or LymphomaWho this might be right forCD19 PositiveCD22 PositiveMinimal Residual Disease+7 more M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT02352558What this trial is testingBBI608 in Adult Patients With Advanced, Refractory Hematologic MalignanciesWho this might be right forHematologic Malignancy Sumitomo Pharma America, Inc. 15
Early research (Phase 1)Study completedNCT00025415What this trial is testingImatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAIDS-related Peripheral/Systemic Lymphoma+78 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT03384654What this trial is testingEvaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaWho this might be right forPrecursor Cell Lymphoblastic Leukemia-Lymphoma Janssen Research & Development, LLC 47
Not applicableStudy completedNCT01629745What this trial is testingGenetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 TrialWho this might be right forLeukemia Children's Oncology Group 99
Testing effectiveness (Phase 2)Ended earlyNCT05032183What this trial is testingTagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaWho this might be right forRecurrent Adult Lymphoblastic LymphomaRecurrent B Acute Lymphoblastic LeukemiaRecurrent T Acute Lymphoblastic Leukemia+3 more M.D. Anderson Cancer Center 4
Not applicableLooking for participantsNCT05541341What this trial is testingEffectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte MalignanciesWho this might be right forDiffuse Large B-cell LymphomaAcute Lymphoblastic LeukemiaFollicular Lymphoma Novartis Pharmaceuticals 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT03541083What this trial is testingBlinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults.Who this might be right forALL, Adult Stichting Hemato-Oncologie voor Volwassenen Nederland 71
Testing effectiveness (Phase 2)Study completedNCT00010283What this trial is testingBeclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00571662What this trial is testingSafety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell TransplantWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+6 more University of Nebraska 76